Introduction {#Sec1}
============

In intensive care units (ICUs), a fluid challenge based on clinical criteria leads to a significant increase in cardiac output (CO) in approximately 50% of patients \[[@CR1]\]. Improving ability to predict fluid responsiveness is of particular interest, given that both persistent hypovolemia and fluid overload are associated with poor clinical outcomes \[[@CR2]-[@CR7]\]. In mechanically ventilated ICU patients, dynamic variables such as pulse pressure variation (PPV) have been shown to be more accurate in predicting fluid responsiveness than static variables such as central venous pressure (CVP) \[[@CR1],[@CR8]\]. The principle of predicting fluid responsiveness through PPV is based on the transmission of positive respiratory pressure generated by controlled mechanical ventilation to the intra-thoracic vascular compartment \[[@CR9]\]. Therefore, spontaneous breathing, mechanical ventilation with low tidal volume (V~T~ \<8 ml/kg^−1^), low plateau pressure, low pulmonary compliance and low heart rate to respiratory rate (HR/RR) ratio reduce the accuracy of PPV in predicting fluid responsiveness \[[@CR10]-[@CR15]\]. These findings challenge the idea that a low PPV value (that is \<13%) excludes fluid responsiveness, whereas a high PPV value accurately predicts fluid responsiveness (as defined by a 15% increase in CO after fluid infusion). A recent study suggests that PPV values \<6% could be associated with fluid responsiveness whereas PPV values ≥10% were highly predictive of a positive response to fluid challenge \[[@CR10]\]. The overlap of PPV values between responders and non-responders reported in previous studies \[[@CR10],[@CR11],[@CR15]\] could be interpreted as a 'grey zone' in which a clinical decision cannot be made with sufficient certainty \[[@CR16]-[@CR19]\]. The grey zone methodology avoids the binary response proposed by the receiver operating characteristic (ROC) curve methodology, which does not take into account the existence of an overlap between responders and non-responders \[[@CR16]-[@CR19]\]. In contrast, the grey zone approach proposes a low cut-off value that excludes fluid responsiveness in 90% of patients (favouring negative predictive value), whereas a high cut-off value predicts fluid responsiveness in 90% of cases (favouring positive predictive value) \[[@CR20]\]. Between these two cut-off values, no decision can actually be taken. Using this method in the anaesthetic setting, Cannesson *et al*. \[[@CR18]\] demonstrated that the grey zone approach identifies a range of PPV values between 9% and 13% for which fluid responsiveness could not be reliably predicted. However, ventilator settings for ICU patients and for patients ventilated during general anaesthesia are different. In this previous report by Cannesson *et al*. \[[@CR18]\], the V~T~ was 7.9 ± 1.3 ml/kg body weight, with 51% of patients being ventilated with V~T~ ≥8 ml/kg^−1^. We recently reported that during anaesthesia, patients were mechanically ventilated with a mean V~T~ =8.8 ± 1.4 ml/kg^−1^ ideal body weight (IBW) and 18% patients were ventilated with a V~T~ \>10 ml/kg^−1^ IBW \[[@CR21]\]. In ICU patients, a low V~T~ (\<8 ml/kg^−1^) has been shown to improve patient outcome in acute respiratory distress syndrome (ARDS) patients and to prevent the occurrence of acute lung injury in mechanically ventilated patients \[[@CR22]-[@CR25]\]. Moreover, our group recently reported that the use of a low V~T~ associated with positive expiratory pressure and recruitment manoeuvres decreases postoperative complication rate and length of stay in ICU \[[@CR26]\]. Therefore, applying the grey zone approach could be informative of the real value of PPV for predicting fluid responsiveness in ICU patients ventilated with low V~T~.

The present study was aimed at assessing the diagnostic accuracy of PPV for prediction of fluid responsiveness by using the grey zone approach in a large ICU population. As a secondary endpoint, we studied respiratory variables that could affect the accuracy of PPV to predict fluid responsiveness (that is V~T~, respiratory driving pressure, respiratory system compliance and HR/RR). We also defined a model for benefit-risk assessment of fluid administration to further evaluate the predictive value of PPV in patients according to their partial arterial oxygen pressure (P~a~O~2~) to inspiratory oxygen fraction (F~i~O~2~) ratio.

Methods {#Sec2}
=======

The present study pooled data obtained from eight published studies (460 patients) in nine French hospitals (one multicentre study having involved ICUs of Orleans, Tours and Paris Bichat hospital) \[[@CR10],[@CR27]-[@CR32]\]. The different local Institutional Review Boards gave their approval for performing previous published studies. In addition, some unpublished data for 96 patients were added. As the physician in charge of the patient prescribed a fluid challenge as part of routine care, the Institutional Review Board of Nîmes, France gave its approval (CHU Nîmes Interface Recherche Bioéthique, IRB number 12-03-03) to perform the present study in new patients who were not included in previous published studies. The patient and/or his/her authorized representative were systematically informed and could decline participation.

Inclusion/exclusion criteria {#Sec3}
----------------------------

Mechanically ventilated and sedated patients with acute circulatory failure in whom a fluid challenge was indicated participated in the study. Acute circulatory failure was defined as systolic arterial blood pressure \<90 mmHg or mean arterial pressure \<65 mmHg with signs of hypoperfusion (oliguria less than 0.5 ml.kg^−1^/h^−1^, arterial lactate \>2.5 mMol/L^−1^, presence of skin mottling, unsuccessful attempt to decrease vasopressor infusion rate). Patients with spontaneous breathing, cardiac arrhythmias, unsatisfactory cardiac echogenicity (in patients in whom CO was assessed by echography), increase in intra-abdominal pressure suspected by clinical context and examination, known tricuspid insufficiency, or cardiogenic pulmonary oedema were excluded. Moribund, parturient patients and those younger than 18 years were not included.

Studied variables {#Sec4}
-----------------

For each patient, age, sex, weight, height, body mass index (BMI), and Acute Physiology and Chronic Health Evaluation (APACHE) II score \[[@CR33]\] or the Simplified Acute Physiology Score II (SAPS II) score \[[@CR34]\] were recorded at admission. IBW (kg) was defined as follows: X +0.91(height (cm) - 152.4), (X = 50 for men and 45.5 for women). Before performing the fluid challenge, the aetiology of acute circulatory failure and the infusion rates of inotropic and/or vasopressor agents were recorded. For ventilator variables, V~T~ (ml/kg^−1^ of IBW), RR (cycles/min^−1^), the level of positive end-expiratory pressure (PEEP, cmH~2~O) and plateau pressure (cmH~2~O), F~i~O~2~, and P~a~O~2~ (mmHg) were recorded when available. The following haemodynamic variables were recorded: HR (beats.min^−1^/bpm) and mean arterial blood pressure (MAP, mmHg). MAP and CVP (when available) were measured invasively with a zero referenced to the middle axillary line. PPV was calculated as follows \[[@CR8]\]:$$\documentclass[12pt]{minimal}
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(PP: pulsed pressure)

In each measurement and after verifying the absence of cardiac arrhythmia and spontaneous breathing, CO was measured either by thermodilution technique (PiCCO system (Pulsion, Medical Systems AG, Munich, Germany) or pulmonary artery catheter (CO-set system (Edwards Lifesciences, Irvine, CA, USA)), echocardiography (General Electric Vivid3 machine; GE Healthcare, Chalfont St. Giles, Buckinghamshire, UK or Acuson CV-70; Siemens Medical, Germany) or oesophageal Doppler (HemoSonic 100; Arrow International, Everett, MA, USA).

Intervention and definition of fluid responsiveness {#Sec5}
---------------------------------------------------

When indicated, a fluid challenge using either colloid or isotonic crystalloid solutions was performed over 15 to 30 minutes. The infused volume was most often 500 ml (500 ml in 527 patients and 20 mL/IBW^−1^ in 29 patients, as performed by Reuter *et al*. \[[@CR35]\]). Fluid responsiveness was defined as an increase in stroke volume (SV) ≥15% compared to baseline value. Studied variables were measured immediately prior to and two to five minutes following the fluid challenge. When the fluid challenge was repeated, only the first was included in the analysis. Ventilatory settings and inotropic and/or vasopressors drug regimens were kept constant as set by the attending physician during the study period.

Statistical analysis {#Sec6}
--------------------

We expected to include a large sample of patients with at least 100 events (responders) to allow an accurate determination of the ROC curves and cut-off values. Assuming a proportion of responders close to 50%, about 200 patients would be necessary. However, because we intended to perform bootstrap analysis and subgroup analyses, we decided to include at least 500 patients, a number close to that previously used by Cannesson *et al*. \[[@CR18]\].

Results are expressed according to variable distributions (mean ± standard deviation (SD) or median (95% confidence interval (95% CI)) for quantitative variables and frequencies with percentages for qualitative variables. Patients were divided into responders and non-responders according to response to fluid challenge. Comparisons were performed using unpaired Student *t* tests, Mann-Whitney tests, chi-square test, and the Fisher exact method when appropriate. Receiver operating characteristic (ROC) curves were created to assess the discriminative power of PPV and CVP to predict the effect of fluid challenge. The ROC curves were also created by using a bootstrap methodology, which creates multiple samples (1,000) by randomly drawing instances, with replacement, from the original study population \[[@CR36]\]. Bootstrapping has been previously used for assigning measures of accuracy to sample estimates and the sample distribution \[[@CR18],[@CR36]\]. This method limits the impact of outliers and provides more robust representations. The area under the ROC curves with 95% CI was calculated. The comparison of two areas under the ROC curves was performed as previously described by DeLong *et al*. \[[@CR37]\].

Threshold and grey zone determination {#Sec7}
-------------------------------------

The grey zone approach determines a range of values for which no conclusion may be drawn concerning potential fluid responsiveness \[[@CR16]-[@CR19],[@CR38]\]. The best threshold for a ROC curve was defined as that which maximizes the Youden index (sensitivity + specificity −1) \[[@CR17]\]. A two-step procedure was performed in order to determine the grey zone. The first step consisted in determining the best threshold in each of the 1,000 bootstrapped populations for PPV and CVP. The 95% CI of the best threshold was defined by the observed distributions of the thresholds in the 1,000 populations \[[@CR36]\]. The second step was aimed at determining the values for which no conclusive information could be provided concerning fluid responsiveness. We defined inconclusive responses for values with sensitivity \<90% or specificity \<90% (diagnostic tolerance of 10%). Two-curve (sensitivity, specificity) representation was provided to illustrate this second step. The grey zone was defined as the values that did not allow a 10% diagnostic tolerance. Nevertheless, if the characteristics of the study population produce a 95% CI of the best thresholds larger than the inconclusive zone, the values obtained during the first step were retained as the grey zone. This two-step procedure allows us to provide robust results not impacted by potential outliers. This approach is particularly interesting when small samples (or rare endpoints) are considered. Because there is no clear consensus for statistical comparison between two grey zones, the percentages of patients in the grey zone for PPV and CVP were compared.

Moreover, grey zones were determined according to potential factors that could impact on the ability of PPV to predict fluid responsiveness.

In patients with ARDS, restrictive fluid management has been shown to be associated with a higher number of ventilator-free days at Day~28~ (ARDS network) and a lower mortality rate \[[@CR39]-[@CR41]\]. In patients with ARDS, the value of P~a~O~2~/F~i~O~2~ ratio could influence the clinician's decision as to perform a fluid challenge or not. For example, a P~a~O~2~/F~i~O~2~ \< 100 with impaired left ventricular function could influence the clinician towards avoiding unnecessary volume loading. In contrast, a patient with a P~a~O~2~/F~i~O~2~ ratio ≥200 and a preserved/normal left ventricular function is a patient in whom fluid loading may be beneficial and the risk of fluid overload may be low. Therefore, a cost ratio (R = cost (false positive)/cost (false negative)) was defined according to the recent international definition of ARDS \[[@CR42]\]. When the P~a~O~2~/F~i~O~2~ ratio was \<100 (severe ARDS group), R was arbitrarily defined as 2 (potential risk = fluid overload). When the P~a~O~2~/F~i~O~2~ ratio was \<200 (moderate ARDS group), R was defined as 1 and when the P~a~O~2~/F~i~O~2~ ratio was ≥200 (mild ARDS group), R was defined as 0.5 (potential risk = hypovolemia). All *P* values were two-sided, and a *P* value \<0.05 was considered significant. Statistical analyses were performed with R 2.15.1 (The R Foundation for Statistical Computing, Vienna, Austria).

Results {#Sec8}
=======

Data from 564 ICU patients were collected (Figure [1](#Fig1){ref-type="fig"}). The assessment of PPV was missing in three patients and no fluid responsiveness was assessed in five other patients. Therefore, 556 patients (197 women) were analysed (Figure [1](#Fig1){ref-type="fig"}). Most of the CO measurements were obtained through thermodilution or ultrasound technique (Figure [1](#Fig1){ref-type="fig"}). Two hundred and forty-three patients (44%) were ventilated with a V~T~ \>8 ml/kg^−1^. The correlation between baseline PPV values and the increase in CO induced by the fluid challenge was 0.23 (*P* \<0.001) (Figure [2](#Fig2){ref-type="fig"}). Central venous pressure was available in 406 patients.Figure 1**Flow chart of the study.**Figure 2**Changes in cardiac output (%) induced by volume expansion according to the baseline PPV value (%).** PPV, pulse pressure variation.

Comparisons between responders and non-responders {#Sec9}
-------------------------------------------------

An increase in SV ≥15% was observed in 267 patients (48%) defined as responders. The comparisons between responders and non-responders are shown in Table [1](#Tab1){ref-type="table"}.Table 1**Characteristics of responders (increase in stroke volume ≥15% after volume expansion) and non-responders to fluid challengeRespondersNon-responders*P*** **value(n = 267)(n = 289)Age**58 ± 1856 ± 170.40**Sex (women/men)**92/175105/1830.68**Height (cm)**169 ± 9 (n = 266)169 ± 9 (n = 288)0.72**Weight (kg)**72 ± 15 (n = 266)75 ± 17 (n = 288)0.053**IBW (kg)**63 ± 10 (n = 266)63 ± 9 (n = 288)0.76**SAPS II score**50 ± 20 (n = 147)53 ± 20 (n = 188)0.13**HR (beats/min)**91 ± 2488 ± 250.066**MAP(mmHg)**73 ± 1575 ± 160.12**RR (cycle/min)**19 ± 6 (n = 231)19 ± 6 (n = 262)0.55**V** ~**T**~ **/IBW (ml/kg)**7.4 ± 2.3 (n = 248)7.6 ± 2.6 (n = 271)0.57**V** ~**T**~ **/IBW \<8 ml/kg (%)**109 (41%)134 (46%)0.24**PEEP**6 ± 5 (n = 249)7 ± 5 (n = 271)0.095**PPlat (cmH** ~**2**~ **O)**19.3 ± 5.5 (n = 205)20.7 ± 5.8 (n = 225)0.014**Driving pressure (cmH** ~**2**~ **O)**14 ± 5 (n = 192)15 ± 5 (n = 211)0.055**C** ~**st,rs**~ **(ml/cmH** ~**2**~ **O)**39.5 ± 14.3 (n = 192)36.0 ± 13.5 (n = 211)0.011**HR/RR**5.0 ± 1.5 (n = 231)4.8 ± 1.6 (n = 262)0.073**HR/RR ≤3.6 (n,%)**231 (17.8%)262 (27.1%)0.018**PaO** ~**2**~ **/FiO** ~**2**~ **ratio**185 ± 107 (n = 111)182 ± 103 (n = 135)0.85**Norepinephrine infusion**\-\-\-\-\--**Dosage (μ.kg** ^**−1**^ **/min** ^**−1**^ **)**0.49 ± 0.67 (n = 158)0.47 ± 0.63 (n = 172)0.75**CVP (mmHg)**9 ± 511 ± 4\<0.001**Baseline SV**60 ± 2174 ± 27\<0.001**PPV (%)**15 ± 99 ± 7\<0.001Data are presented as means ± standard deviation (SD); n = number of available data. CVP, central venous pressure; C~st,rs~, static compliance of the respiratory system; driving pressure = plateau pressure - positive end-expiratory pressure; HR, heart rate; IBW, ideal body weight; MAP, mean arterial pressure; PaO~2~/FiO~2~ ratio, partial arterial oxygen pressure to inspiratory oxygen fraction ratio; PEEP, positive end-expiratory pressure; PPlat, plateau pressure; PPV: pulse pressure variation; RR, respiratory rate; SAPS II, Simplified Acute Physiology Score II; SV, stroke volume; V~T~, tidal volume.

Grey zone approach for the overall population {#Sec10}
---------------------------------------------

Using a bootstrap analysis, the median values of the area under the ROC curve of PPV and CVP were 0.73 (95% CI = 0.68 to 0.77) and 0.64 (95% CI = 0.59 to 0.70), respectively (*P* \<0.001) (Figure [3](#Fig3){ref-type="fig"}). The 95% CIs for the best threshold values were 9 to 14% and 6 to 9 mmHg, respectively. Because no unique best cut-off value can be obtained using the bootstrap method, the best cut-off values for PPV and CVP with the ROC curve were obtained from the original population (without bootstrap analysis). These best cut-off values were 7% (specificity = 0.71, sensitivity = 0.63, positive likelihood ratio = 2.17, negative likelihood ratio = 0.52) and 10 mmHg (specificity = 0.67, sensitivity = 0.70, positive likelihood ratio = 2.12, negative likelihood ratio = 0.45) for PPV and CVP, respectively. There were 96/564 (17%) patients with a PPV value \<4%.Figure 3**Bootstrapping of ROC curves of pulse pressure variation (PPV) (a) and central venous pressure (CVP) (b).** ROC curve areas are expressed as mean value with 95% confidence interval.

Using the alternative grey zone approach, inconclusive values spreading from 4 to 17% and from 6 to 15 mmHg were found for PPV and CVP, respectively (Figure [4](#Fig4){ref-type="fig"}). There were 62% and 71% patients in the grey zone of PPV and CVP, respectively (*P* \<0.01).Figure 4**Grey zones of pulse pressure variation (PPV) (a) and central venous pressure (CVP) (b).** Blue curve: sensitivity; red curve: specificity; green curve: percentage of patients.

Factors influencing the ability of PPV to predict fluid responsiveness {#Sec11}
----------------------------------------------------------------------

Table [2](#Tab2){ref-type="table"} shows the influence of the following variables that have been shown to influence the ability of PPV to predict fluid responsiveness: V~T~, driving pressure (plateau pressure - PEEP), respiratory compliance (V~T~/(plateau pressure - PEEP), HR/RR ratio, use of vasopressors. Only a V~T~ ≥8 ml/kg^−1^ (*P* \<0.001) and a driving pressure \>20 cmH~2~O (*P* \<0.001) were associated with a significantly greater area under the ROC curve for PPV. Figure [5](#Fig5){ref-type="fig"} shows the grey zones according to the considered centre (Amiens, Lyon and Paris were studied as 'others' because the numbers of included patients were small), and factors that could influence the ability to discriminate responders and non-responders.Table 2**Ability of pulse pressure variations to predict an increase of more than 15% in cardiac output after volume expansion according to tidal volume, driving pressure, respiratory compliance, heart rate/respiratory rate ratio and vasopressor useAUC ROC 95% CIOptimal threshold (%)Gray zoneV** ~**T**~ **/IBW (ml/kg)\<8 (n = 280)**0.69 (0.64-0.73)92-17≥**8 (n = 276)**0.77 (0.73-0.81)^a^128-19**Driving pressure (cm H** ~**2**~ **0)**≤ **20 (n = 356)**0.67 (0.63-0.72)73-17**\>20 (n = 51)**0.78 (0.74-0.82)^b^1412-21**C** ~**st,rs**~ **(mL/cm H** ~**2**~ **0)**≤ **30 (n = 145)**0.60 (0.51-0.70)122-21**\>30 (n = 262)**0.73 (0.67-0.79)73-17**HR/RR**≤ **3.6 (n = 114)**0.65 (0.54-0.76)71-12**\>3.6 (n = 384)**0.73 (0.68-0.78)105-17**VasopressorYes (n = 249)**0.70 (0.66-0.75)143-16**No (n = 307)**0.72 (0.69-0.77)106-18Data are presented as medians (95% confidence intervals). ^a^: *P* \<0.001 vs \<8 ml.kg^−1^; ^b^: *P* \<0.001 vs ≤20 cm H~2~0). AUC, area under the receiver operating characteristics curves, C~st,rs,~ static compliance of the respiratory system; HR/RR, heart rate/respiratory rate ratio; V~T~ /IBW, tidal volume/ideal body weight ratio.Figure 5**Grey zone according to the centre (centres in which the number of inclusion was under 70 were pooled together) and factors influencing on the ability of PPV to predict fluid responsiveness.** Each bar represents the grey zone of the corresponding centre with its lowest limit (specificity ≥90%), its best threshold and its highest limit (sensitivity ≥90%).

Risk/benefit analysis {#Sec12}
---------------------

A P~a~O~2~/F~i~O~2~ ratio was available for 250 patients. For the severe group (n = 57), the best threshold value for PPV was 7%, AUC = 0.67 (95% CI = 0.54 to 0.80), grey zone = 1% to 12%; for the moderate group (n = 111), the best threshold value for PPV was 5%, AUC = 0.73 (95% CI = 0.60 to 0.80), grey zone = 2 to 14%; for the mild group (n = 82) the best PPV threshold value was 12%, AUC = 0.67 (95% CI = 0.57 to 0.74), grey zone = 2 to 14%. For the whole population, when the clinical risk of fluid infusion during ARDS was taken into account by the ratio of costs for severe and mild groups, the best threshold values for PPV and CVP were 14% and 2 mmHg, respectively. When taking into account the risk of fluid infusion in the whole population, the grey zone for PPV was 2% to 13%.

Discussion {#Sec13}
==========

The present study demonstrated that, when using a grey zone approach in a large population of mixed ICU patients: (1) PPV cannot reliably predict fluid responsiveness when its value is between 4% to 17%; (2) 62% of patients (with criteria of valid PPV) had PPV values within this grey zone; (3) a V~T~ ≥8 ml/kg^−1^ and/or driving pressure \>20 cmH~2~O significantly improve the ability of PPV to predict fluid responsiveness; and (4) even when taking into account the risk of fluid loading in ARDS patients, the grey zone remains too large (2 to 13%) to be informative.

Our results are in accordance with previous large reports that emphasized the superiority of dynamic over static variables, but contrast with the very high predictive value of PPV previously reported \[[@CR1],[@CR43]\]. This apparent contradiction is mainly due to substantial changes in ventilatory practices during the past 15 years (the lung protective strategy) in the ICU. The lung protective strategy is based on the use of low V~T~ in patients with ARDS to prevent baro- or volo-trauma. In the early 2000s, dynamic variables were validated in critically ill patients ventilated with high V~T~ (\>8 mL/kg^−1^ of IBW) \[[@CR1],[@CR8],[@CR9],[@CR43],[@CR44]\]. Subsequent studies showed that low V~T~, low driving pressure or low pulmonary compliance significantly impairs the ability of dynamic variables to predict fluid responsiveness \[[@CR10],[@CR11],[@CR13],[@CR15],[@CR45],[@CR46]\]. Because the present study involved ICU patients who were mainly (but not systematically) mechanically ventilated with low V~T~ (\<8 ml/kg^−1^ of IBW), our hypothesis is that low V~T~ is the main explanation for the poor predictive performance of PPV. This hypothesis is supported by the fact that PPV accuracy is improved in patients with driving pressure \>20 cmH~2~O and V~T~ \>8 mL/kg^−1^. The PPV is due to the transmission of pulmonary pressure to the intra-thoracic circulatory compartment and thus, V~T~ and driving pressure directly participate in the pressure transmitted to intra-thoracic components. Surprisingly, in the present report, the compliance of the respiratory system did not modify the ability of PPV to predict fluid responsiveness. In a recent study, Monnet *et al*. \[[@CR46]\] showed that the ability of PPV to predict fluid responsiveness was inversely related to compliance but not to V~T~. To elucidate such conflicting results, a study using oesophageal pressure (reflecting pressure in the pleural space) could be useful to precise the effect of pulmonary pressure on PPV \[[@CR47]\]. Finally, the poor predictive performance of PPV reported in the present study may be due to the relatively low level of PEEP. Freitas *et al*. \[[@CR48]\] recently reported that automated PPV accurately predicted fluid responsiveness in septic patients using a protective lung ventilation strategy (V~T~ =6 mL/kg^−1^). However, in this study, a relatively high PEEP level (\>10 cmH~2~O) was applied in contrast with the present report and with Monnet's \[[@CR46]\] study (average PEEP =6 cmH~2~O). Indeed, a high level of PEEP could facilitate the transmission of pulmonary pressure to the intra-thoracic circulatory compartment and explain these apparent conflicting results. Specific studies are needed to elucidate this point especially with recording of pleural pressure.

In the present study, pooled data were obtained from studies where V~T~ \>7 to 8 ml/kg was an inclusion criterion, with positive results (that is, a high predictive value for fluid responsiveness) and cut-off values around 12% \[[@CR27],[@CR28],[@CR32]\] with studies performed in patients ventilated with smaller tidal volumes (around 6 ml/kg), where poor results and low cut-off values (around 5 to 7%) were reported \[[@CR10],[@CR32]\]. This wide range of tidal volume can explain the importance of the grey zone value (4 to 17%) and the variation of grey zone value among centres. This value is considerably larger in those previously published in surgical patients ventilated with relatively high and fixed tidal volume (8 mL/kg) that ranged from 9 to 13% \[[@CR18]\]. The present results show that, whatever tidal volume value, a PPV value \<17% lead to a risk of false negative. The present results also show that a high PPV value (\>17%) whatever the tidal volume value is often associated with a positive fluid responsiveness. Finally, in the present report, a V~T~ ≥8 ml/kg^−1^ and/or a driving pressure \>20 cmH~2~O significantly improve the ability of PPV to predict fluid responsiveness.

The potential deleterious consequences of unwarranted fluid infusion are crucial during ARDS since a restrictive strategy has been shown to reduce mechanical ventilation duration in these patients \[[@CR5],[@CR40],[@CR41]\]. The grey zone in the severe, moderate or mild ARDS groups was too large to be clinically informative. For severe ARDS patients (P~a~O~2~/F~i~O~2~ ratio \<100), we considered that the risk of excessive fluid infusion was twice as high when compared with less severe patients. For the severe ARDS group, our results show that when applying a cost ratio of 2 (two-fold increased risk in case of fluid infusion) the best cut-off value for PPV moved from 7 to 14%. This suggests that the more severe the ARDS, the higher the cut-off, in order to limit the risk of unnecessary fluid loading. Nevertheless, because the grey zones were 1 to 12% for the moderate ARDS group, 1 to 14% for the mild ARDS group and 2 to 14% for the severe ARDS group, we failed to show any relevant difference in the grey zone regardless of severity.

Clinical implications: when a given value of PPV is in the grey zone, physicians cannot use this index to proceed with or to exclude the need for fluid therapy in the ICU. In such a case, a passive leg-raising test, an end-expiratory occlusion test or 'minifluid' challenge could be valuable alternatives in ventilated patients with low V~T~ \<8 mL.kg^−1^ even if these indices have yet to be assessed with a grey zone approach \[[@CR32],[@CR46]\]. Conversely, when a measured value is outside of the grey zone, the necessity of performing a fluid challenge can be confirmed (value above the upper limit of the grey zone) or excluded (value below the lower limit of the grey zone) with less than 10% error (specificity and sensitivity \>90%). At the bedside, the grey zone appears to be more informative than the confidence interval of the best threshold value obtained with the ROC curve methodology \[[@CR16],[@CR18],[@CR19]\]. Interestingly, the grey zone varied according to the considered centre. This probably reflected the different management of such patients in each centre. Therefore, this finding probably means that the concept of the grey zone should be adapted according to the local policy of fluid challenge, mechanical ventilation and others factors that could influence PPV predictive value.

The present study shows a grey zone of 4 to 17%, meaning that PPV cannot reliably guide fluid loading in 62% of studied population. Only rarely (17% of the study population), when under the threshold of 4%, does PPV rule out any use of fluid loading, which could then be avoided. In contrast, a PPV value above 17% can be considered as a useful tool to indicate fluid infusion. Nevertheless, an isolated value of PPV (even above 17%) cannot be considered as the sole argument to decide fluid therapy. The latter should be only considered when signs of a clinical hypoperfusion are associated with PPV value above 17%. In other words, PPV should be considered as a tool, not as a target. Moreover, the great variability according to the centres suggests that the patient case mix and different management protocols could influence the reliability of PPV to predict fluid responsiveness.

It could be hypothesized that the important variation of grey zone value among centres probably reflects the fact that PPV was measured by different techniques. In particular, PPV was manually or automatically measured according to each study centre's procedures. This heterogeneity reflects the real daily practice of PPV. There may be differences between absolute PPV values obtained from automated or manual calculation. There may also be differences between different automatic devices. Finally, it is also possible that actual criteria for accurate PPV measurement were not uniform among centres at the time of study, especially for right ventricle failure detection \[[@CR49]\]. This highlights the fact that, as previously demonstrated for filling pressure a rigorous technique for PPV measurement is of particular importance \[[@CR50]\]. In the same way, it could be objected that the conditions of PPV validity chosen for the present report do not reflect the actual recommendation. The criteria used reflect what was recommended at the time of publication of the main studies used for the present report \[[@CR49]\]. These criteria do not reflect the actual recommendations, especially for tidal volume and right ventricle failure \[[@CR49]\].

Our study presents several limitations that should be considered when assessing the clinical relevance of our results. First, this study is not prospective, which limits the power of the conclusions. Second, the methods of PPV and CO measurements were not uniform and this may have extended the PPV grey zone. However, thermodilution and echocardiography have both been validated and this methodological issue was considered as acceptable in a previous report \[[@CR18]\]. Furthermore, patients with clinical or suspected intra-abdominal pressure syndrome were excluded because the latter can affect dynamic indicators of fluid responsiveness, especially by increasing the threshold value of PPV \[[@CR51],[@CR52]\]. However, a clinical examination (as performed in the present study) cannot rule out an intra-abdominal pressure syndrome. The lack of direct measurement of intra-abdominal pressure could partially explain the large grey zone found in the present study \[[@CR52]\]. Third, the present study pooled the findings of different centres and different ICU populations. Figure [5](#Fig5){ref-type="fig"} clearly shows the heterogeneity between centres, corresponding to the real PPV daily practice. Fourth, the present main finding, that is a grey zone of PPV between 4 to 17%, should be validated in a prospective study including different patients in different ICUs. Fifth, the existence of a right ventricle failure was not systematically ruled out before measuring PPV in hypoxemic patients. This is due to the fact that, at the time of publication of the main studies involved in the present report, right ventricle failure was not a usual non-validity criterion for PPV assessment. Sixth, as the baseline levels of stroke volume are substantially different in responders and non-responders, we cannot rule out the fact that our findings reflect regression artefact. Finally, as mentioned above, the relation between PPV accuracy, respiratory system compliance, driving pressure or PEEP level remains unclear and is still debated. Physiological studies measuring pleural space pressure or oesophageal pressure may better explain the decreased reliability of PPV for predicting fluid responsiveness in mechanically ventilated ICU patients with low V~T~. All these limitations are emphasized by the limited number of patients in whom PPV can be measured. Indeed, recommendations in sedation and in mechanically ventilation tend to favour spontaneously breathing modes in order to decrease the duration of mechanical ventilation \[[@CR53],[@CR54]\]. These practices may decrease the clinical utility of PPV as recently reported in the anaesthetic setting \[[@CR55]\]. In addition, it must be kept in mind that the increase in stroke volume is not always associated to a greater oxygen delivery to cells that is the main objective of a fluid challenge.

Conclusions {#Sec14}
===========

In ventilated ICU patients, the grey zone approach identifies a wide range of PPV values, between 4 and 17%, for which fluid responsiveness cannot be accurately predicted, corresponding to 62% of patients in whom criteria for measuring PPV are valid. The heterogeneity in measurement method and in tidal volume value can contribute to the present findings.

Key messages {#Sec15}
============

In 564 ICU mechanically ventilated patients, a grey zone approach showed that pulsed pressure variations (PPV) cannot reliably predict fluid responsiveness when its value is between 4% and 17%In this population, 62% of patients (with criteria of valid PPV) had PPV values within this grey zoneA V~T~ ≥8 ml/kg^−1^ and/or driving pressure \>20 cmH~2~O significantly improve the ability of PPV to predict fluid responsivenessEven when taking into account the risk of fluid loading in ARDS patients, the grey zone remains too large (2 to 13%) to be informative.
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